Successful treatment of epidermal growth factor receptor inhibitor-induced periungual inflammation with adapalene

Hachisuka, J. , Doi, K., Moroi, Y. and Furue, M. (2011) Successful treatment of epidermal growth factor receptor inhibitor-induced periungual inflammation with adapalene. Case Reports in Dermatology, 3(2), pp. 130-136. (doi:10.1159/000329914) (PMID:21743808) (PMCID:PMC3130494)

[img]
Preview
Text
194764.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

857kB

Abstract

Epidermal growth factor receptor (EGFR) inhibitors are increasingly used for cancer treatment, but commonly carry dermatologic side effects. Periungual inflammation is a particularly painful condition that additionally worsens quality of life. In this paper, we report 3 cases of successful treatment of periungual inflammation induced by 3 different EGFR inhibitors (gefitinib, erlotinib, and cetuximab) with topically applied adapalene.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Hachisuka, Dr Junichi
Authors: Hachisuka, J., Doi, K., Moroi, Y., and Furue, M.
College/School:College of Medical Veterinary and Life Sciences > Institute of Neuroscience and Psychology
Journal Name:Case Reports in Dermatology
Publisher:Karger
ISSN:1662-6567
ISSN (Online):1662-6567
Published Online:30 June 2011
Copyright Holders:Copyright © 2011 S. Karger AG
First Published:First published in Case Reports in Dermatology 3(2): 130-136
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record